WallStSmart

Compass Inc (COMP)vsEUDA Health Holdings Limited (EUDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Compass Inc generates 154667% more annual revenue ($10.56B vs $6.82M). COMP leads profitability with a 0.6% profit margin vs -40.7%. COMP earns a higher WallStSmart Score of 57/100 (C).

COMP

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 3.5Value: 3.0Quality: 5.0
Piotroski: 2/9Altman Z: 2.52

EUDA

Avoid

24

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -47.30
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COMPSignificantly Overvalued (-44.7%)

Margin of Safety

-44.7%

Fair Value

$7.74

Current Price

$10.51

$2.77 premium

UndervaluedFair: $7.74Overvalued

Intrinsic value data unavailable for EUDA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COMP3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
109.0%10/10

Revenue surging 109.0% year-over-year

EPS GrowthGrowth
60.3%10/10

Earnings expanding 60.3% YoY

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

EUDA2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
78.9%10/10

Revenue surging 78.9% year-over-year

Debt/EquityHealth
-0.5610/10

Conservative balance sheet, low leverage

Areas to Watch

COMP4 concerns · Avg: 3.0/10
Return on EquityProfitability
0.5%3/10

ROE of 0.5% — below average capital efficiency

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

Operating MarginProfitability
3.8%3/10

Operating margin of 3.8%

Debt/EquityHealth
1.383/10

Elevated debt levels

EUDA4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$40.81M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-2.50M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : COMP

The strongest argument for COMP centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 109.0% demonstrates continued momentum.

Bull Case : EUDA

The strongest argument for EUDA centers on Revenue Growth, Debt/Equity. Revenue growth of 78.9% demonstrates continued momentum.

Bear Case : COMP

The primary concerns for COMP are Return on Equity, Profit Margin, Operating Margin. A P/E of 168.8x leaves little room for execution misses. Thin 0.6% margins leave little buffer for downturns.

Bear Case : EUDA

The primary concerns for EUDA are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

COMP carries more volatility with a beta of 2.33 — expect wider price swings.

COMP is growing revenue faster at 109.0% — sustainability is the question.

COMP generates stronger free cash flow (180M), providing more financial flexibility.

Monitor REAL ESTATE SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

COMP scores higher overall (57/100 vs 24/100) and 109.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Compass Inc

REAL ESTATE · REAL ESTATE SERVICES · USA

Urban Compass, Inc., which is Compass, is a real estate brokerage company. The company is headquartered in New York, New York.

EUDA Health Holdings Limited

REAL ESTATE · REAL ESTATE SERVICES · USA

EUDA Health Holdings Limited is a forward-looking biopharmaceutical company focused on innovating treatments for rare diseases and addressing unmet medical needs. Leveraging advanced technologies, the firm is developing a robust clinical pipeline with a particular emphasis on supportive care and immune modulation. EUDA's strong commitment to research and development positions it favorably in the healthcare landscape, aiming to enhance patient outcomes and expand access to crucial therapies.

Visit Website →

Want to dig deeper into these stocks?